SARS-CoV-2 mRNA Vaccine-Induced Cellular and Humoral Immunity in Hemodialysis Patients

Background/Aims: Chronic kidney disease CKD patients on intermittent hemodialysis IHD are exposed to SARS-CoV-2 infection and carry a risk of developing severe symptoms. The aim of this study was to evaluate the humoral and cellular immunity induced by two doses of mRNA vaccines, the Pfizer-BioNTech...

Descripción completa

Detalles Bibliográficos
Autores principales: Kwiatkowska, Ewa, Safranow, Krzysztof, Wojciechowska-Koszko, Iwona, Roszkowska, Paulina, Dziedziejko, Violetta, Myślak, Marek, Różański, Jacek, Ciechanowski, Kazimierz, Stompór, Tomasz, Przybyciński, Jarosław, Wiśniewski, Piotr, Kwella, Norbert, Kwiatkowski, Sebastian, Prystacki, Tomasz, Marcinkowski, Wojciech, Domański, Leszek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8945424/
https://www.ncbi.nlm.nih.gov/pubmed/35327438
http://dx.doi.org/10.3390/biomedicines10030636

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8945424/
https://www.ncbi.nlm.nih.gov/pubmed/35327438
http://dx.doi.org/10.3390/biomedicines10030636

Ejemplares similares